Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
Active, not recruiting · NCT04165330 · Registry updated 2025-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, sarcoma, small cell lung carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2025-02-24 | NCT04165330 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Advenchen Laboratories, LLC | 4 |
| Sarcoma Oncology Research Center, LLC | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sarcoma Oncology Research Center | Santa Monica | United States | 9 |